Life Molecular Imaging
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Tegeler St 6-7, Berlin, Berlin, 13353, G...Phone Number
+49 30461124603Website
www.life-mi.comRevenue
$64.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Life Molecular Imaging
Life Molecular Imaging specializes in developing innovative molecular imaging tracers for neuroimaging and cardiovascular imaging, aiming to improve the early detection and characterization of chronic and life-threatening diseases. Their lead product, Neuraceq, is used in PET imaging to evaluate beta amyloid neuritic plaque density in patients suspected of Alzheimer's disease. The company collaborates with pharmaceutical partners and is engaged in research and development to address clinical needs in neurology and cardiology. They focus on enhancing diagnostic capabilities and personalizing patient care to improve therapeutic outcomes.Explore more
Life Molecular Imaging Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Life Molecular Imaging your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Life Molecular Imaging launches new products
Earning: See what the market has to say on Life Molecular Imaging recently announced quarterly report
Life Molecular Imaging, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Life Molecular Imaging has new funding data
Check if Life Molecular Imaging has recently received funding, and reach out quickly before it becomes old news!
Check out if Life Molecular Imaging is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Life Molecular Imaging
Click to see if Life Molecular Imaging had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Life Molecular Imaging
Compare insights from companies similar to Life Molecular Imaging, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Life Molecular Imaging
$64.1M
51-200
Private
<$5M
2012
LJ
Leah JimmersonGlobal Director, Regulatory Affairs & Pharmacovigilance
Company Profile Activity
Activity Insights
Life Molecular Imaging is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Life Molecular Imaging is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Life Molecular Imaging.
Life Molecular Imaging financials insights
Gather financial insights about Life Molecular Imaging, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$2.2M
Life Molecular Imaging Tech Stack
A closer look at the technologies used by Life Molecular Imaging
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Partnership
Partnership, Product Management, Manufacturing Operations, Warehouse Operations
Life Molecular Imaging News & Media
Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging
LMI is the maker of Neuraceq, a globally approved F-18 positron emission tomography imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s.Life Molecular Imaging and SOFIE announce Neuraceq® availability in Albany, NY
Improved Neuraceq® supply capabilities to enhance patient access to amyloid PET. BOSTON, May 20, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, and...Life Molecular Imaging announces Neuraceq® availability at PharmaLogic Salt Lake City
Enhanced the supply capabilities of Neuraceq® to increase patient access to beta-amyloid PET imaging BOSTON, April 24, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI) and PharmaLogic Holdings Corp. (PharmaLogic), a world-class contract development and manufacturing organization (CDMO)...Life Healthcare to sell stake in pharmaceutical business for $75mn - CNBC Africa
CNBC Africa is joined by Peter Wharton-Hood, CEO, Life Healthcare.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Life Molecular Imaging
Sign Up For FreeTo access detailed company insights
Life Molecular Imaging specializes in developing innovative molecular imaging tracers for neuroimaging and cardiovascular imaging, aiming to improve the early detection and characterization of chronic and life-threatening diseases. Their lead product, Neuraceq, is used in PET imaging to evaluate beta amyloid neuritic plaque density in patients susp... Read More
